Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Oct;21(10):2917-2928.
doi: 10.1016/j.jtha.2023.06.018. Epub 2023 Jun 25.

Identification of genomic loci regulating platelet plasminogen activator inhibitor-1 in mice

Affiliations

Identification of genomic loci regulating platelet plasminogen activator inhibitor-1 in mice

Amy E Siebert et al. J Thromb Haemost. 2023 Oct.

Abstract

Background: Plasminogen activator inhibitor-1 (PAI-1, Serpine1) is an important circulating fibrinolysis inhibitor. PAI-1 exists in 2 pools, packaged within platelet α-granules and freely circulating in plasma. Elevated plasma PAI-1 levels are associated with cardiovascular disease. However, little is known about the regulation of platelet PAI-1 (pPAI-1).

Objectives: We investigated the genetic control of pPAI-1 levels in mice and humans.

Methods: We measured pPAI-1 antigen levels via enzyme-linked immunosorbent assay in platelets isolated from 10 inbred mouse strains, including LEWES/EiJ (LEWES) and C57BL/6J (B6). LEWES and B6 were crossed to produce the F1 generation, B6LEWESF1. B6LEWESF1 mice were intercrossed to produce B6LEWESF2 mice. These mice were subjected to genome-wide genetic marker genotyping followed by quantitative trait locus analysis to identify pPAI-1 regulatory loci.

Results: We identified differences in pPAI-1 between several laboratory strains, with LEWES having pPAI-1 levels more than 10-fold higher than those in B6. Quantitative trait locus analysis of B6LEWESF2 offspring identified a major pPAI-1 regulatory locus on chromosome 5 from 136.1 to 137.6 Mb (logarithm of the odds score, 16.2). Significant pPAI-1 modifier loci on chromosomes 6 and 13 were also identified.

Conclusion: Identification of pPAI-1 genomic regulatory elements provides insights into platelet/megakaryocyte-specific and cell type-specific gene expression. This information can be used to design more precise therapeutic targets for diseases where PAI-1 plays a role.

Keywords: blood platelets; fibrinolysis; gene expression regulation; megakaryocytes; quantitative trait loci; serpin E1.

PubMed Disclaimer

Conflict of interest statement

Declaration of competing interests There are no competing interests to disclose.

Figures

Figure 1:
Figure 1:. Mouse Strain-Specific pPAI-1 Expression.
(A) Quantification of total pPAI-1 derived from inbred laboratory and wild-derived mouse strains was performed by mouse PAI-1 total antigen ELISA assay. Prior to lysis, platelet samples were normalized to 400,000 platelets/μL. *The reduced pPAI-1 levels in two LEWES/EiJ mouse strain mice may reflect commercially obtained mice that were contaminated with WSB/EiJ strain mice. (B) Genome-wide summary neighbor joining phylogeny of 63 inbred strains depicting the relationships of the inbred mouse strains analyzed by PAI-1 ELISA. The tree was rooted at the most recent common ancestor of M. m. castaneus and M. m. musculus wild-derived strains. Mouse strains analyzed here are depicted in larger font. (C) Plasma PAI-1 antigen levels measured by ELISA. Grey dots and text represent inbred laboratory strains and red dots and text represent wild-derived strains.
Figure 2:
Figure 2:. Semidominant Serpine1 Regulatory Locus.
(A) Total pPAI-1 from platelet lysates normalized for total protein (150 μg/mL). (B) LEWES pPAI-1 sex differences. (C) RT-PCR of platelet Serpine1 expression (NTC=no template control). Actb expression serves as control. (D) qPCR of platelet Serpine1 expression. *p<0.05, ****p<0.0001.
Figure 3:
Figure 3:. RT-qPCR data of relative Serpine1 mRNA expression in B6 and LEWES whole liver and adipose tissue samples.
No significant differences were detected in Serpine1 expression (n=3 per group, p=NS)
Figure 4:
Figure 4:. QTL Analysis of pPAI-1 Levels in B6LEWESF2 mice.
(A-D) LOD curves from the QTL analysis for pPAI-1 levels, with close-ups of the significant peaks on Chromosome 5 (B), 6 (C), and 13 (D). The horizontal solid and dashed lines represent the thresholds for significant QTL (LOD=4.01) and suggestive QTL (LOD=2.65), respectively. (E) Effect plot of the strain alleles at SNP marker UNC050425680 (136.1 Mb) on Chromosome 5 (B/B: 3.3 ± 0.6, B/L: 37.2 ± 2.3, L/L: 57.7 ± 6.7 fg/ug total protein, ****p<0.0001). (F) Effect plot of the allelic sex differences at SNP marker UNC050425680 on Chromosome 5 (B/B F: 3.0 ± 1.02, B/B M: 3.6 ± 1.9, B/L F: 39.3 ± 2.9, B/L M: 35.4 ± 3.5, L/L F: 62.0 ± 10.7, L/L M: 53.8 ± 8.2 fg/ug total protein). (G) LOD curve of Chromosome 8 from the QTL with sex as an interactive covariate. Black curve is the single QTL analysis and red curve is the sex as a covariate QTL. Dashed line represents the threshold for suggestive QTL (LOD=3.76). (H) Effect plot of the allelic sex differences at SNP marker UNC081450048 (126.9 Mb) on Chromosome 8 (B/B F: 22.2 ± 4.9, B/B M: 46.9 ± 9.6, B/L F: 31.3 ± 5.3, B/L M: 26.6 ± 5.8, L/L F: 59.3 ± 8.6, L/L M: 34.1 ± 4.3 fg/ug total protein, *p<0.05). B/B=homozygous B6, B/L=heterozygous, and L/L=homozygous LEWES.

References

    1. Baker SK, Strickland S. A critical role for plasminogen in inflammation. Journal of Experimental Medicine. 2020;217(4). - PMC - PubMed
    1. Virani SS, Alonso A, Aparicio HJ, et al. Heart Disease and Stroke Statistics-2021 Update A Report From the American Heart Association. Circulation. 2021;143(8):e254–e743. - PubMed
    1. Klarin D, Busenkell E, Judy R, et al. Genome-wide association analysis of venous thromboembolism identifies new risk loci and genetic overlap with arterial vascular disease. Nat Genet. 2019;51(11):1574–1579. - PMC - PubMed
    1. Sillen M, Declerck PJ. Targeting PAI-1 in Cardiovascular Disease: Structural Insights Into PAI-1 Functionality and Inhibition. Frontiers in Cardiovascular Medicine. 2020;7. - PMC - PubMed
    1. Westrick RJ, Eitzman DT. Plasminogen activator inhibitor-1 in vascular thrombosis. Curr Drug Targets. 2007;8(9):966–1002. - PubMed

Publication types

Substances

LinkOut - more resources